• Sectors we work in banner(2)

    Quick Reads

Is now the optimal time to sell your company?

If your focus is on net after tax cash receipts, then now could be the time to initiate a sale process before the "window" closes in March/April 2022.

Earlier this year, prior to the Chancellor presenting his budget on 3 March, there was a frenzy of M&A activity amid much speculation that rates of CGT would be increased. But with the UK's economic recovery in such a fledging state at the time, the economic consensus moved against increases until later in the year, by which time the recovery was expected to have taken hold.

While a final decision on the budget has yet to be made, the Chancellor is being told there is a case for waiting until spring 2022. Given that a successful sales processes typically takes anything from 6 to 9 to 12 months to execute, now could be the time for founders, entrepreneurs and managers to act.

Rishi Sunak weighs up moving budget to 2022 on back of Covid crisis

Our thinking

  • Policy; Private Capital & Digital Transformation: What to look for in the Investors & Entrepreneurs’ space in 2025

    Mike Barrington

    Insights

  • Charles Russell Speechlys appoints new Corporate Partner in Singapore

    Simon Green

    News

  • Updated HMRC guidance following Vermilion Holdings: when is a securities option “employment-related”?

    Tessa Newman

    Insights

  • Keir Gordon and Molly Moseley write for City AM on the Miami Dolphins and Buffalo Bills becoming the first NFL teams to sign private equity deals

    Keir Gordon

    In the Press

  • In-House Insights - Building and Contributing to High-Performing In-House Legal Teams

    Megan Paul

    Insights

  • United Arab Emirates Private M&A Comparative Guide

    William Reichert

    Insights

  • The EU Deforestation Regulation: an update and what it means for companies

    Kerry Stares

    Insights

  • Bloomberg quotes Giles Dennison on positive trends in the UK's M&A market

    Giles Dennison

    In the Press

  • Charles Russell Speechlys advises SAI MedPartners on its acquisition of IDEA Pharma

    Daniel Rosenberg

    News

  • Law360 quotes Ashwin Pillay on UniCredit's €10bn offer for Italian rival Banco BPM

    Ashwin Pillay

    In the Press

  • Takeover Panel confirms narrowing of Takeover Code jurisdiction: Key Changes Set for February 2025

    Noah Ofulue

    Insights

  • The eVisa rollout – what do employers need to do?

    Rose Carey

    Insights

  • Investing in Africa’s digital economy – the brink of a digital revolution

    Nnamdi Nwokedi

    Quick Reads

  • New Commercial Register Law of Saudi Arabia

    Ahmad Anani

    Insights

  • Companies House releases its inaugural Strategic Intelligence Report

    Cheryl Tham

    Quick Reads

  • Navigating the Legal Landscape of Non-Performing Loan Acquisitions in the UAE

    William Reichert

    Quick Reads

  • Autumn Budget 2024: Share incentives

    Tessa Newman

    Quick Reads

  • Charles Russell Speechlys advises Lovett Care on its acquisition of New Care

    David Coates

    News

  • Charles Russell Speechlys advises The Nero Group on its acquisition of coffee brand 200 Degrees

    Keir Gordon

    News

  • Autumn budget - Capital Gains Tax increase and divorce settlements

    Sarah Higgins

    Quick Reads

Back to top